📰 Valuating News
Page 7 - Valuating News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Valuating. Real-time updates on events, politics, business and more.
April 3, 2023
Contract demonstrates the agency’s continued commitment to evaluating the acquisition of commercial radio frequency data for situational awareness and intelligence ... | April 3, 2023
March 31, 2023
Company Continues Process of Evaluating Strategic Alternatives to Enhance Shareholder Value ... | March 31, 2023
March 29, 2023
Intra-Cellular Therapies, Inc. announced positive topline results from Study 403 evaluating lumateperone 42mg as monotherapy in the treatment of major depressive episodes in patients with major... | March 29, 2023
March 28, 2023
Study 014/015 is a Phase II trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia Full data suggest a new strategy for the management of TRS patients in... | March 28, 2023
March 28, 2023
Toronto, Ontario--(Newsfile Corp. - March 28, 2023) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution
March 28, 2023
CyberArk Introduces Peer-Based Framework for Evaluating and Maturing Identity Security Strategies ... | March 28, 2023
March 27, 2023
By Cecilia Butini Novartis AG said Monday that a trial evaluating breast-cancer drug Kisqali met its primary endpoint during an interim analysis. The drug is shown to significantly reduce... | March 27, 2023
March 27, 2023
TME PHARMA ANNOUNCES 83% OF GLIOBLASTOMA PATIENTS STILL ALIVE AFTER 12 MONTHS ON STUDY IN GLORIA EXPANSION ARM EVALUATING NOX-A12 IN COMBINATION WITH... | March 27, 2023
March 8, 2023
By Chris Wack Protagonist Therapeutics Inc. said Tuesday it saw positive topline results from its collaboration with Janssen Biotech Inc. in a Phase 2b clinical trial evaluating the oral... | March 7, 2023
March 3, 2023
-- Enrolled first patient in CHASE Phase 2b clinical trial evaluating KPI-012 for PCED; Top-line data targeted for 1Q 2024 -- -- Closed $31.0 million... | March 3, 2023